Carrera Capital Advisors Buys Shares of 10,731 DocuSign, Inc. (NASDAQ:DOCU)

Carrera Capital Advisors acquired a new position in shares of DocuSign, Inc. (NASDAQ:DOCUFree Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 10,731 shares of the company’s stock, valued at approximately $666,000.

Other large investors also recently added to or reduced their stakes in the company. J.W. Cole Advisors Inc. increased its stake in shares of DocuSign by 2.0% during the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after buying an additional 155 shares during the period. Resonant Capital Advisors LLC lifted its position in DocuSign by 0.9% in the third quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock valued at $1,088,000 after acquiring an additional 157 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in DocuSign by 6.0% in the third quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock valued at $187,000 after acquiring an additional 172 shares in the last quarter. Dakota Wealth Management boosted its holdings in shares of DocuSign by 0.8% in the second quarter. Dakota Wealth Management now owns 23,022 shares of the company’s stock valued at $1,232,000 after acquiring an additional 181 shares during the period. Finally, Covestor Ltd boosted its stake in DocuSign by 5.8% during the 3rd quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after purchasing an additional 182 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on DOCU. Wells Fargo & Company upped their price target on DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a research note on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, September 6th. Bank of America increased their target price on DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Citigroup lifted their price target on DocuSign from $86.00 to $87.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Finally, Robert W. Baird raised their price objective on shares of DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $63.40.

View Our Latest Report on DocuSign

DocuSign Trading Up 1.5 %

NASDAQ:DOCU traded up $1.18 on Tuesday, hitting $82.40. 735,536 shares of the stock were exchanged, compared to its average volume of 2,880,327. The stock has a market cap of $16.72 billion, a PE ratio of 17.14, a PEG ratio of 8.40 and a beta of 0.90. DocuSign, Inc. has a fifty-two week low of $40.64 and a fifty-two week high of $82.54. The stock has a fifty day moving average of $65.20 and a 200-day moving average of $58.85.

DocuSign (NASDAQ:DOCUGet Free Report) last issued its earnings results on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The company had revenue of $736.03 million during the quarter, compared to the consensus estimate of $727.20 million. During the same quarter in the prior year, the business earned $0.09 earnings per share. The company’s revenue was up 7.0% compared to the same quarter last year. As a group, analysts predict that DocuSign, Inc. will post 1.01 earnings per share for the current year.

Insider Activity at DocuSign

In other news, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the transaction, the director now owns 7,202 shares of the company’s stock, valued at approximately $407,345.12. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other DocuSign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total value of $30,203.04. Following the completion of the transaction, the director now owns 7,202 shares in the company, valued at approximately $407,345.12. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Allan C. Thygesen sold 7,725 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $59.09, for a total value of $456,470.25. Following the completion of the sale, the chief executive officer now owns 102,193 shares in the company, valued at approximately $6,038,584.37. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 69,558 shares of company stock valued at $4,272,768 over the last ninety days. Corporate insiders own 1.66% of the company’s stock.

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.